Promotion Versus Precaution: The Evolution of Biotechnology Policy in the United States

Adam D. Sheingate

British Journal of Political Science, 2006, vol. 36, issue 2, 243-268

Abstract: Biotechnology policy in the United States promotes the commercial development of genetically modified crops, yet adopts a precautionary approach when it comes to stem cells and cloning. In this article, the evolution of this bifurcated policy domain is traced. A detailed analysis of congressional hearings shows how distinctions between the products of biotechnology came to be reflected in the character of committees holding hearings, the attention to risks and benefits, and the pattern of interest-group activity in different biotechnology applications. It is argued that many of the differences that separate the United States and Europe in biotechnology reflect the way institutions reinforce past policy choices.

Date: 2006
References: Add references at CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
https://www.cambridge.org/core/product/identifier/ ... type/journal_article link to article abstract page (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:cup:bjposi:v:36:y:2006:i:02:p:243-268_00

Access Statistics for this article

More articles in British Journal of Political Science from Cambridge University Press Cambridge University Press, UPH, Shaftesbury Road, Cambridge CB2 8BS UK.
Bibliographic data for series maintained by Kirk Stebbing ().